Accelerating psoriatic arthritis detection in patients with psoriasis

Accelerating psoriatic arthritis detection in patients with psoriasis
Enrolling By Invitation
18 years - 99 years
All
Phase N/A
1 Location

Brief description of study

The study will aim to develop a direct-to-patient screening approach that will improve early psoriatic arthritis (PsA) detection, without burdening dermatologists with PsA screening tasks. We hypothesize that disseminating questionnaires directly to patients outside of a clinic setting will improve early PsA detection, by educating a diverse population of psoriasis patients about their PsA risk, including patients not attending dermatology clinics.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: psoriasis
  • Age: 18 years - 99 years
  • Gender: All

Male and Female, age 18 or older with psoriasis

Updated on 04 Aug 2024. Study ID: 832666
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research